. 2011 Jul-Sep;28(3):193–200. doi: 10.4103/0970-2113.83977
© Lung India
This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Table 1.
Newer anti-TB drugs in clinical development
